A Study of Mitomycin C, Irinotecan, and Cetuximab

Clinical trial NCT00271011 · TERMINATED

Trial details

NCT number: NCT00271011
Sponsor: University of Michigan Rogel Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2005-12-01
Primary completion: 2008-07-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.